Glenmark Life Sciences is a Pharmaceutical company company operating in the pharmaceutical industry.
Glenmark Life Sciences Limited, is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes. The company is increasingly providing CDMO services to a range of multinational and specialty pharmaceutical companies. It has a diversified portfolio of more than 137 molecules and supplies its products to customers in India, Europe, North America, Latin America, Japan and the rest of the world (ROW).
Company type
Pharmaceutical company
Products and services
Custom Manufacturing, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Glenmark Life Sciences on LinkedIn
Address
Glenmark Life Sciences, Glenmark House,Andheri, Mumbai, MAHARASHTRA, India, 400099
